Healthcare News and Headlines
Healthcare News and Headlines
Four firms—BusTest Express, Odulair, CGS Premier, and Mission Mobile Medical—offer distinct pathways for organizations to launch mobile health clinics. BusTest Express provides a turnkey lease model that bundles vehicles, drivers, compliance and logistics. Odulair builds modular vans, trucks or containers that meet CDC, WHO and ISO standards, with flexible financing. CGS Premier designs custom trailers, vans and RVs equipped for telehealth, solar power and ADA compliance. Mission Mobile Medical adds strategic program design and ongoing operational support, positioning itself as a B‑Corp focused partner.
A BioSpace webinar highlighted how biotech firms can close the expectation gap with the FDA to avoid last‑minute decision‑day setbacks. Speakers emphasized the FDA’s recent pledge—led by Commissioner Marty Makary and CBER Director Vinay Prasad—to provide regulatory navigation for small companies,...
Wambūi Karanja turned her father's early‑onset dementia into a catalyst for change, creating a practical guide and training program for family caregivers in Kenya. She highlighted pervasive myths that label dementia as normal aging or a spiritual curse, which delay...
Moody’s has kept a negative outlook on the U.S. health‑insurance sector, citing persistent medical‑cost inflation that is crushing profit margins. EBITDA margins have slipped into the low‑single‑digit range as loss ratios climb faster than premium hikes. Insurers are expected to...
Spokane County Fire District 9 will launch its own ambulance service on July 1, offering free transport to district residents after American Medical Response doubled its rates. The district has purchased three new cherry‑red ambulances at roughly $385,000 each and expects the...
Most older Americans lack long‑term care (LTC) insurance despite the high cost of services, which average $80,000 annually for home care and over $130,000 for a private nursing‑home room. Medicare provides only limited LTC coverage, while Medicaid requires individuals to...
Under PDUFA VI, BsUFA II and GDUFA II, the FDA has launched a Resource Capacity Planning (RCP) capability and modernized time‑reporting to better match staffing with the growing volume and complexity of drug and biologic submissions. The RCP system quantifies needed resources, while...
GlaxoSmithKline announced that the European Medicines Agency has accepted the marketing authorization application for bepirovirsen, an antisense oligonucleotide targeting chronic hepatitis B. The acceptance follows positive Phase III data from the B‑Well 1 and B‑Well 2 trials, which enrolled patients...
Severance Hospital in South Korea has created an AI model, LiMPC, that predicts early liver metastasis in pancreatic cancer patients using routine blood tests. The model was trained on data from 2,657 patients and externally validated on 272 patients from...
South Korean AI firms are expanding into the U.S. market as Neurophet signs an MOU with the Alzheimer’s Network for Treatment and Diagnostics (ALZ‑NET) to provide FDA‑cleared imaging software for amyloid monitoring, and JLK receives FDA 510(k) clearance for its...
AstraZeneca’s in‑vivo CAR‑T platform, acquired last year, has entered a Phase I/II trial in China for relapsed/refractory multiple myeloma. Early data show a 33% overall response rate with several partial remissions, but the study also reported one death due to severe...
The NCCN has revised its guidelines to place checkpoint inhibitors at the forefront of cutaneous squamous cell carcinoma (CSCC) treatment, extending their use beyond metastatic disease to neoadjuvant and adjuvant settings. PD‑1/PD‑L1 agents such as cemiplimab, cosibelimab and pembrolizumab are...
GLP‑1 receptor agonists are booming in the United States, where roughly 12 % of patients use them, but European uptake lags at about 2 % across the EU and UK. Consumer skepticism—especially in France, Italy and Spain—and the dominance of public‑health reimbursement...
Emergency cholera kits intended for Chad, Sudan and South Sudan are stranded in Dubai warehouses because the Iran‑linked conflict has disrupted shipping routes. The World Health Organization and the International Federation of Red Cross and Red Crescent Societies are scrambling...
A multinational GAAPP survey of 1,401 adults with uncontrolled asthma found that only 11% of patients who meet guideline eligibility are currently using biologic therapies. The most common reason for discontinuation was difficulty fitting injections into daily routines (37%), followed...
The CMS Innovation Center has obligated $11.4 billion from 2011 through 2024 to test 70 health‑care delivery and payment models, with 24 still active as of January 2025. Annual obligations peaked at $1.3 billion in FY 2015 and dropped nearly 40 percent to $789 million in...
Novartis announced it will pay up to $2 billion upfront to acquire Excellergy Inc., securing the biotech’s next‑generation anti‑IgE candidate. The move comes as Xolair, Novartis’ blockbuster allergy drug, prepares for imminent biosimilar competition that could erode its market share. By...
A University of Illinois study found that more than 98% of full‑time wheelchair and scooter users worry about falling, and 68% reported a fall‑related injury in the past year. Researchers created the Fall Concerns Scale, a device‑specific tool that captures...
Recursion Therapeutics announced the appointment of Vicki Goodman as its new chief medical officer, bringing her extensive oncology and drug‑development experience from a decade as CMO at Exelixis. Goodman will oversee clinical strategy for Recursion’s AI‑driven pipeline, aiming to accelerate...
Researchers at UCLA Health and Stanford Medicine reported that a neoadjuvant regimen combining hypofractionated radiation, the experimental immunomodulator BO‑112, and anti‑PD‑1 therapy (nivolumab) can reshape the tumor microenvironment of soft‑tissue sarcoma. Preclinical mouse work and a Phase I trial in 14...
The article argues that extending healthspan—years lived in good health—should eclipse the pursuit of sheer longevity. It highlights the growing gap between longer lifespans and rising chronic disease burdens, urging a shift toward interventions that improve quality of life. Researchers...
Researchers at UC San Diego introduced the MetALD‑ALD Prediction Index (MAPI), a biomarker panel that leverages routine blood tests to differentiate alcohol‑associated liver disease from metabolic steatotic liver disease. In a 503‑patient US cohort, MAPI achieved 60% sensitivity, 80% specificity,...
The Queensland Crisafulli government announced a sweeping overhaul of its public health service boards, adding 50 new members. Among the appointees are former LNP MP Darren Zanow to the West Moreton board, Cairns candidate Yolonde Entsch to the Torres and Cape...
AstraZeneca announced that its investigational COPD antibody achieved positive results in two Phase 3 trials, marking a turnaround after a previous mid‑stage failure. The studies demonstrated statistically significant improvements in lung function and exacerbation rates across a broader patient population...
A preclinical study in Small describes an inulin‑butyrate nanogel that releases butyrate directly in the inflamed colon of mice, markedly improving colitis outcomes. The nanogel remains stable through the upper GI tract and is enzymatically activated by colonic microbes, delivering...
South Korean AI firm Neurophet has signed a memorandum of understanding with the Alzheimer’s Network for Treatment and Diagnostics (ALZ‑NET) to build an imaging‑monitoring infrastructure for emerging Alzheimer’s therapies. The deal brings Neurophet’s FDA‑cleared tools—Aqua, Scale PET, and Aqua AD...
myTomorrows, a Dutch health‑tech firm, has partnered with Spain’s Clínica Universidad de Navarra (CUN) to embed an AI‑driven clinical‑trial matching engine directly into CUN’s electronic health record. The system leverages large language models to parse multilingual unstructured notes and structured...
Simulations Plus has launched strategic partnership programmes with three pharmaceutical companies to embed AI‑driven modelling into the drug development lifecycle. The collaborations will integrate Simulations Plus platforms—ADMET Predictor, GastroPlus, Thales and MonolixSuite—into model‑informed drug development (MIDD) workflows, enabling natural‑language interaction and automated...
A new population study in The Lancet Healthy Longevity found that older adults who experience delirium during a hospital stay face a three‑fold higher risk of developing dementia later, even if they entered the hospital with few or no chronic...
The 31st Annual Executive War College will convene April 28‑29 in New Orleans, bringing together clinical laboratory executives to address reimbursement, staffing, compliance, and emerging technologies. A new Executive Forum on Digital Pathology Management will spotlight AI‑driven workflows and data...
The West Hancock Ambulance Service, a volunteer‑run EMS provider serving Britt and surrounding Iowa towns, marked its 50th anniversary with a community celebration on July 19. Founded in early 1976 after local funeral homes ended ambulance operations, thirteen residents pooled...
Primary care physicians handle a wide range of everyday health issues, from respiratory infections to chronic disease screening. The article outlines nine common conditions they treat, emphasizing early detection and continuity of care. It highlights how primary care can spot...
An 18‑month strength‑training trial involving 377 knee‑OA patients boosted hip‑abductor, hamstring and quadriceps strength but did not lower knee joint loading or pain. A post‑hoc analysis of the 88 strongest responders confirmed significant muscle gains—45% in quadriceps, 68% in hamstrings,...
HaemaLogiX, an Australian clinical‑stage biotech, is developing precision immunotherapies for multiple myeloma by targeting novel antigens KMA and LMA that appear only on malignant plasma cells. Peer‑reviewed research validates these targets, allowing the company to spare healthy plasma cells and...
The Trump administration touts recent reductions in Affordable Care Act (ACA) enrollment fraud while unveiling a sweeping set of 2027 regulations aimed at tightening eligibility verification and curbing broker misconduct. Complaints about unauthorized enrollments climbed to 341,906 in 2025, prompting...
Northwestern Medicine has upgraded its mobile stroke unit (MSU) with a 32‑slice CT scanner, replacing the older 16‑slice system. The new, smaller‑footprint vehicle can perform advanced imaging en route, allowing clinicians to differentiate ischemic from hemorrhagic strokes before hospital arrival....
Wearable devices have moved beyond consumer hype, offering concrete value for healthcare providers. The article outlines five practical pathways—remote patient monitoring, EHR integration, patient engagement tools, security/compliance foundations, and focused use‑case design—to embed wearable data without overhauling existing IT stacks....
A cross‑sectional analysis of 4,118 U.S. adults aged 20‑69, published in *Neurourology and Urodynamics*, found that overactive bladder (OAB) is independently linked to a higher recent‑fall risk. OAB prevalence was 19.6% while 28.3% of participants reported a fall in the...
:max_bytes(150000):strip_icc()/Doctor-Prescribe-Food-Instead-Pills-FT-DGTL0326-4bb1f3563aa84f99aeedcee9688121ce.jpg)
The Rockefeller Foundation’s new report projects that expanding Food Is Medicine programs to the 43 million Americans with diet‑related conditions could generate roughly $45 billion in economic activity, create 316,000 jobs, and funnel more than $5.6 billion to small and mid‑size farms. Medically...
Abcuro presented Phase II/III MUSCLE trial data for ulviprubart (ABC008) in inclusion body myositis (IBM) at the GCOM 2026 meeting. The study enrolled 272 patients who received either 0.5 mg/kg, 2 mg/kg, or placebo. Across the entire cohort the drug showed only...
Phio Pharmaceuticals (NASDAQ:PHIO) and Galectin Therapeutics (NASDAQ:GALT) are small‑cap biotech stocks compared across nine investment factors. Phio enjoys stronger institutional backing (57% vs 12%) and a higher consensus target price of $14, implying over 1,000% upside, while Galectin’s target is...
On March 5, 2026, HL7 International launched the Caliper FHIR Accelerator, an implementation community aimed at real‑time medical device data interoperability. The initiative builds on HL7’s 2025 device‑workgroup and aligns with standards from IEEE, ISO, IEC, and IHE. By extending...
Georgia Tech’s Advanced Technology Development Center announced that two of its HealthTech portfolio companies, Nephrodite and OrthoPreserve, have each received the FDA’s Breakthrough Device designation. The program promises accelerated regulatory interaction, more frequent agency meetings, and priority review. Nephrodite’s solution...
Researchers from Brazil’s Federal University of São Carlos and University College London examined 12 years of data from 5,440 adults aged 50 and older and discovered that the coexistence of abdominal obesity and low muscle mass—known as sarcopenic obesity—raises mortality...
Senior HHS official and Medicare administrator Chris Klomp warned that competition with China’s rapidly advancing biotech sector is “a war,” signaling heightened urgency in U.S. policy circles. He highlighted gaps in domestic research funding, manufacturing capacity, and talent pipelines that...
Laboratory automation is becoming essential as testing volumes surge and workflows grow more complex. Leading diagnostic vendors—Danaher, Siemens Healthineers, and Abbott—offer end‑to‑end platforms that integrate pre‑analytic sorting, AI‑driven error detection, and post‑analytic data management. Danaher’s DxA 5000 claims up to an...
Health‑care stocks surged 11.47% in Q4 2025, the strongest sector gain in the S&P 500, while the Fidelity Select Health Care Portfolio (FSPHX) posted an 11.10% return, slightly trailing the MSCI health‑care index. The fund’s underperformance stemmed from an underweight position...
